Mounjaro leads South Africa’s $187 million weight-loss drug boom as Aspen prepares Ozempic rival
South Africa’s market for GLP-1 medicines is approaching $187 million (R3 billion). Aspen says Mounjaro, which it distributes locally, is the market leader. The company...